litlas
Log inCreate account

Eitan Amir

Active 2003–2025

131
Papers
19,059
Citations
72
h-index
120
i10-index

Citations

Citations per year for Eitan Amir1992: 1 citations1999: 1 citations2000: 1 citations2004: 2 citations2006: 5 citations2007: 3 citations2008: 7 citations2009: 10 citations2010: 17 citations2011: 41 citations2012: 58 citations2013: 79 citations2014: 97 citations2015: 122 citations2016: 198 citations2017: 203 citations2018: 184 citations2019: 737 citations2020: 964 citations2021: 918 citations2022: 718 citations2023: 501 citations2024: 795 citations2025: 472 citations2026: 8 citations1993–1998: no citations, so these years are not shown2001–2003: no citations, so these years are not shown2005: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,836 citing papers, 20.1% of this breakdownChina: 1,199 citing papers, 13.1% of this breakdownUnited Kingdom: 625 citing papers, 6.8% of this breakdownItaly: 571 citing papers, 6.3% of this breakdownCanada: 452 citing papers, 4.9% of this breakdownGermany: 334 citing papers, 3.7% of this breakdownJapan: 333 citing papers, 3.6% of this breakdownFrance: 289 citing papers, 3.2% of this breakdownSpain: 277 citing papers, 3% of this breakdownNetherlands: 271 citing papers, 3% of this breakdownAustralia: 246 citing papers, 2.7% of this breakdownBelgium: 188 citing papers, 2.1% of this breakdown
0%20.1%Other 27.5%

Institutions

Fields

  • Medicine68.5%
  • Biochemistry, Genetics and Molecular Biology19.4%
  • Immunology and Microbiology5.2%
  • Computer Science1.3%
  • Economics, Econometrics and Finance1.1%
  • Engineering0.7%
  • Other3.8%

Topics

  • Inflammatory Biomarkers in Disease Prognosis6.2%
  • Cancer Immunotherapy and Biomarkers5%
  • Chemotherapy-induced cardiotoxicity and mitigation3.6%
  • Immune cells in cancer2.5%
  • Breast Cancer Treatment Studies2.4%
  • HER2/EGFR in Cancer Research1.9%
  • Other78.4%

Coauthors

All papers

Open in search
  1. Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis

    Authors: Arnoud J. Templeton, Mairéad G. McNamara, Boštjan Šeruga, Francisco Vera-Badillo, Priya Aneja, Alberto Ocaña, Raya Leibowitz‐Amit, Guru Sonpavde, Jennifer J. Knox, Ben Tran, Ian F. Tannock, Eitan Amir - JNCI Journal of the National Cancer Institute 2014 cited by 3,272

  2. PDK1-Dependent Metabolic Reprogramming Dictates Metastatic Potential in Breast Cancer

    Authors: Fanny Dupuy, Sébastien Tabariès, Sylvia Andrzejewski, Zhifeng Dong, Julianna Blagih, Matthew G. Annis, Atilla Ömeroğlu, Dongxia Gao, Samuel Leung, Eitan Amir, Mark Clemons, Adriana Aguilar‐Mahecha, Mark Basik, Emma E. Vincent, Julie St‐Pierre, Russell G. Jones, Peter M. Siegel - Cell Metabolism 2015 cited by 556

  3. Prognostic role of neutrophil-to-lymphocyte ratio in breast cancer: a systematic review and meta-analysis

    Authors: Josée-Lyne Ethier, Danielle Desautels, Arnoud J. Templeton, Prakesh S. Shah, Eitan Amir - Breast Cancer Research 2017 cited by 693

  4. Assessment of Prognostic Value of Left Ventricular Global Longitudinal Strain for Early Prediction of Chemotherapy-Induced Cardiotoxicity

    Authors: Evangelos K. Oikonomou, Damianos G. Kokkinidis, Polydoros Ν. Kampaktsis, Eitan Amir, Thomas H. Marwick, Dipti Gupta, Paaladinesh Thavendiranathan - JAMA Cardiology 2019 cited by 410

  5. Strain-Guided Management of Potentially Cardiotoxic Cancer Therapy

    Authors: Paaladinesh Thavendiranathan, Tomoko Negishi, Emily Somerset, Kazuaki Negishi, Martin Pěnička, Julie Lemieux, Svend Aakhus, Sakiko Miyazaki, Mitra Shirazi, Maurizio Galderisi, Thomas H. Marwick, Kazuaki Negishi, Ben Costello, Leah Wright, André La Gerche, Phil Mottram, Liza Thomas, Mitra Shirazi, Martin Pěnička, Tomáš Ondrúš, Stéphanie Seldrum, Krassimira Hristova, Paaladinesh Thavendiranathan, Eitan Amir, Babitha Thampinathan, Julie Lemieux, Marc‐André Côté, Jonathan Deblois, Manish Bansal, Maurizio Galderisi, Ciro Santoro, Koji Kurosawa, Nobuaki Fukuda, Hirotsugu Yamada, Yoshihito Saijo, Sakiko Miyazaki, Masaki Izumo, Tomomi Suzuki, Kazuko Tajiri, Goo‐Yeong Cho, Svend Aakhus, Klaus Murbræch, Richard J. Massey, Wojciech Kosmala, Maciej Siński, Dragoş Vinereanu, Diana Mihalcea, Bogdan A. Popescu, Andreea Călin, Evgeny Shkolnik, José Banchs, Shelby Kutty - Journal of the American College of Cardiology 2020 cited by 380

  6. Statins to prevent early cardiac dysfunction in cancer patients at increased cardiotoxicity risk receiving anthracyclines

    Authors: Paaladinesh Thavendiranathan, Christian Houbois, Thomas H. Marwick, Tiffanie Kei, Sudipta Saha, Kyle Runeckles, Flora Huang, Tamar Shalmon, Kevin E. Thorpe, Rossanna C. Pezo, Anca Prica, Dawn Maze, Husam Abdel‐Qadir, Kim A. Connelly, Joyce Y.T. Chan, Filio Billia, Coleen Power, Kate Hanneman, Bernd J. Wintersperger, Christine Brezden‐Masley, Eitan Amir - European Heart Journal - Cardiovascular Pharmacotherapy 2023 cited by 106

  7. Prognostic Role of Platelet to Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis

    Authors: Arnoud J. Templeton, Olga Ace, Mairéad G. McNamara, Mustafa Al-Mubarak, Francisco Vera-Badillo, Thomas Hermanns, Boštjan Šeruga, Alberto Ocaña, Ian F. Tannock, Eitan Amir - Cancer Epidemiology Biomarkers & Prevention 2014 cited by 715

  8. HYPE or HOPE: the prognostic value of infiltrating immune cells in cancer

    Authors: T. Barnes, Eitan Amir - British Journal of Cancer 2017 cited by 442

  9. Integrating artificial intelligence in drug discovery and early drug development: a transformative approach

    Authors: Alberto Ocaña, Atanasio Pandiella, Cristian Privat, Iván Bravo, Miguel Luengo-Oroz, Eitan Amir, Balázs Győrffy - Biomarker Research 2025 cited by 132

  10. Acute kidney injury associated with immune checkpoint inhibitor therapy: incidence, risk factors and outcomes

    Authors: Alejandro Meraz-Muñoz, Eitan Amir, Pamela Ng, Carmen Ávila-Casado, Claire Ragobar, Christopher T. Chan, S. Joseph Kim, Ron Wald, Abhijat Kitchlu - Journal for ImmunoTherapy of Cancer 2020 cited by 193

  11. HER2 heterogeneity and resistance to anti-HER2 antibody-drug conjugates

    Authors: Alberto Ocaña, Eitan Amir, Atanasio Pandiella - Breast Cancer Research 2020 cited by 96

  12. Delivering affordable cancer care in high-income countries

    Authors: Richard Sullivan, Jeffrey Peppercorn, Karol Sikora, John Zalcberg, Neal J. Meropol, Eitan Amir, David Khayat, Peter Boyle, Philippe Autier, Ian F. Tannock, Tito Fojo, Jim Siderov, Steve Williamson, Silvia Camporesi, J. Gordon McVie, Arnie Purushotham, Peter Naredi, Alexander Eggermont, Murray F. Brennan, Michael L. Steinberg, Mark De Ridder, Susan A. McCloskey, Dirk Verellen, Terence Roberts, Guy Storme, Rodney J. Hicks, Peter J. Ell, Bradford R. Hirsch, David P. Carbone, Kevin A. Schulman, Paul Catchpole, David Taylor, Jan Geißler, Nancy Brinker, David Meltzer, David Kerr, Matti Aapro - The Lancet Oncology 2011 cited by 714

  13. Adjuvant Therapy in the Treatment of Biliary Tract Cancer: A Systematic Review and Meta-Analysis

    Authors: Anne M. Horgan, Eitan Amir, Thomas Walter, Jennifer J. Knox - Journal of Clinical Oncology 2012 cited by 720

  14. A Population-Based Study of Cardiovascular Mortality Following Early-Stage Breast Cancer

    Authors: Husam Abdel‐Qadir, Peter C. Austin, Douglas S. Lee, Eitan Amir, Jack V. Tu, Paaladinesh Thavendiranathan, Kinwah Fung, George Anderson - JAMA Cardiology 2016 cited by 311

  15. Association of Obesity With Breast Cancer Outcome in Relation to Cancer Subtypes: A Meta-Analysis

    Authors: Ana Elisa Lohmann, Sara V. Soldera, Isabel Pimentel, Domen Ribnikar, Marguerite Ennis, Eitan Amir, Pamela J. Goodwin - JNCI Journal of the National Cancer Institute 2021 cited by 117

  16. Toxicity of Adjuvant Endocrine Therapy in Postmenopausal Breast Cancer Patients: A Systematic Review and Meta-analysis

    Authors: Eitan Amir, Boštjan Šeruga, Saroj Niraula, Lindsay Carlsson, Alberto Ocaña - JNCI Journal of the National Cancer Institute 2011 cited by 624

  17. Statin Exposure and Risk of Heart Failure After Anthracycline‐ or Trastuzumab‐Based Chemotherapy for Early Breast Cancer: A Propensity Score‒Matched Cohort Study

    Authors: Husam Abdel‐Qadir, David Bobrowski, Limei Zhou, Peter C. Austin, Oscar Calvillo‐Argüelles, Eitan Amir, Douglas S. Lee, Paaladinesh Thavendiranathan - Journal of the American Heart Association 2021 cited by 99

  18. Comparison of treatment-related adverse events of different Cyclin-dependent kinase 4/6 inhibitors in metastatic breast cancer: A network meta-analysis

    Authors: Alexandra Desnoyers, Michelle B. Nadler, Vikaash Kumar, Ramy Saleh, Eitan Amir - Cancer Treatment Reviews 2020 cited by 91

  19. Informative censoring — a neglected cause of bias in oncology trials

    Authors: Arnoud J. Templeton, Eitan Amir, Ian F. Tannock - Nature Reviews Clinical Oncology 2020 cited by 96

  20. Cardiovascular toxicity of angiogenesis inhibitors in treatment of malignancy: A systematic review and meta-analysis

    Authors: Husam Abdel‐Qadir, Josée-Lyne Ethier, Douglas S. Lee, Paaladinesh Thavendiranathan, Eitan Amir - Cancer Treatment Reviews 2016 cited by 254

  21. HER3 Overexpression and Survival in Solid Tumors: A Meta-analysis

    Authors: Alberto Ocaña, Francisco Vera-Badillo, Boštjan Šeruga, Arnoud J. Templeton, Atanasio Pandiella, Eitan Amir - JNCI Journal of the National Cancer Institute 2012 cited by 223

  22. Incidence, Diagnosis, and Management of QT Prolongation Induced by Cancer Therapies: A Systematic Review

    Authors: Andreu Porta‐Sánchez, Cameron Gilbert, Danna Spears, Eitan Amir, Joyce Chan, Kumaraswamy Nanthakumar, Paaladinesh Thavendiranathan - Journal of the American Heart Association 2017 cited by 218

  23. Toxicity of Extended Adjuvant Therapy With Aromatase Inhibitors in Early Breast Cancer: A Systematic Review and Meta-analysis

    Authors: Hadar Goldvaser, T. Barnes, Boštjan Šeruga, David W. Cescon, Alberto Ocaña, Domen Ribnikar, Eitan Amir - JNCI Journal of the National Cancer Institute 2017 cited by 184

  24. Impact of Geriatric Assessment and Management on Quality of Life, Unplanned Hospitalizations, Toxicity, and Survival for Older Adults With Cancer: The Randomized 5C Trial

    Authors: Martine Puts, Naser Alqurini, Fay J. Strohschein, Rama Koneru, Ewa Szumacher, Caroline Mariano, Johanne Monette, Tina Hsu, Sarah Brennenstuhl, Bianca McLean, Aria Wills, Arielle Berger, Eitan Amir, Lindy Romanovsky, Anson Li, Rajin Mehta, Monika K. Krzyzanowska, Christine Elser, Raymond Jang, Anca Prica, D. Wan-Chow-Wah, Eric Pitters, Urban Emmenegger, Ines B. Menjak, Simon Bergman, Manon Lemonde, Henriette Breunis, François Béland, Shabbir M.H. Alibhai - Journal of Clinical Oncology 2022 cited by 80